OGT Updates SureSeq NGS Portfolio
The latest update is beneficial to researchers investigating myeloid disorders, and is now enabled with BCR-ABL fusion gene and KMT2A-PTD detection.
Read MorePosted by | Apr 10, 2020 | Cancer, Leukemia, Molecular Diagnostics |
The latest update is beneficial to researchers investigating myeloid disorders, and is now enabled with BCR-ABL fusion gene and KMT2A-PTD detection.
Read MorePosted by | Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types |
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read MorePosted by | Mar 31, 2020 | Computing Systems, Information Technology, Middleware & Software |
Qlucore is expanding its bioinformatics software business into precision medicine and precision diagnostics.
Read MorePosted by | Mar 27, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
A Quebec research team has just received the green light from the CIHR to test a device that will shorten the response time for detecting covid-19.
Read MorePosted by | Mar 16, 2020 | Cancer, Leukemia, Microarray Systems, Molecular Diagnostics |
The panel has been tested to show excellent concordance with array data, and can detect both small and large CNVs, indels, LOH, and SNVs.
Read More